(S1 (S (S (NP (NP (JJ Pharmacological) (NN analysis)) (PP (IN of) (NP (NP (NN signal) (NN transduction) (NNS pathways)) (VP (VBN required) (PP (IN for) (NP (NP (JJ oxidative) (NN burst)) (PP (IN in) (NP (NN chicken) (NNS heterophils))))))))) (VP (VBN stimulated) (PP (IN by) (NP (DT a) (JJ Toll-like) (NN receptor) (CD 2) (NN agonist))))) (. .)))
(S1 (S (S (NP (NP (JJ Toll-like) (NNS receptors)) (PRN (-LRB- -LRB-) (NP (NNS TLRs)) (-RRB- -RRB-))) (VP (VBP play) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (DT the) (JJ innate) (JJ immune) (NN response)) (PP (IN of) (NP (JJ avian) (NNS heterophils))))))) (. .)))
(S1 (S (S (NP (PRP We)) (ADVP (RB previously)) (VP (VBD used) (NP (NP (DT the) (JJ pharmacological) (NNS inhibitors)) (NP (NP (NN genistein)) (, ,) (NP (NN verapamil)) (, ,) (NP (NN chelerythrine)) (, ,) (CC and) (NP (NN pertussis) (NN toxin)))) (S (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (JJ upstream) (NN signaling) (NNS events)) (VP (VBN involved) (PP (IN in) (NP (NP (JJ TLR2-mediated) (JJ oxidative) (NN burst)) (PP (IN in) (NP (NN chicken) (NNS heterophils)))))))))))) (. .)))
(S1 (S (S (NP (RB Only) (NP (NN chelerythrine)) (, ,) (NP (DT a) (NN protein) (NN kinase) (NN C) (NN inhibitor)) (, ,)) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (ADVP (RB significantly)) (VP (VB inhibit) (NP (NP (JJ oxidative) (NN burst)) (VP (VBN stimulated) (PP (IN by) (NP (NP (DT the) (NN TLR2) (NN agonist) (JJ lipoteichoic) (NN acid)) (PRN (-LRB- -LRB-) (NP (NN LTA)) (-RRB- -RRB-)))))))))))) (. .)))
(S1 (S (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP (PRP we)) (VP (VBD used) (NP (JJ selective) (JJ pharmacological) (NNS inhibitors)) (S (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (NNS roles)) (PP (IN of) (NP (NP (NP (NN phosphatidylinositol-3'-kinase)) (PRN (-LRB- -LRB-) (NP (NN PI3-K)) (-RRB- -RRB-))) (, ,) (NP (NP (NP (NN phospholipase) (NN C)) (PRN (-LRB- -LRB-) (NP (NN PLC)) (-RRB- -RRB-))) (, ,) (NP (NP (JJ calcium-dependent) (NN protein) (NN kinase) (NN C)) (PRN (-LRB- -LRB-) (NP (NN PKC)) (-RRB- -RRB-))) (, ,) (NP (NP (JJ extra-cellular) (NN signal) (JJ regulated) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NN ERK)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (JJ nuclear) (NN translocation) (NN factor) (NN kappa) (NN B)) (PRN (-LRB- -LRB-) (NP (NN NF-kappaB)) (-RRB- -RRB-)))))) (PP (IN on) (NP (JJ TLR2-mediated) (JJ oxidative) (NN burst))))))))) (. .)))
(S1 (S (NP (NP (NP (NN U-73122)) (PRN (-LRB- -LRB-) (NP (DT a) (NN PLC) (NN inhibitor)) (-RRB- -RRB-))) (, ,) (NP (NP (NP (NP (NN wortmannin)) (PRN (-LRB- -LRB-) (NP (DT a) (NN PI3-K) (NN inhibitor)) (-RRB- -RRB-))) (, ,) (NP (NN PD) (CD 98059))) (PRN (-LRB- -LRB-) (NP (DT an) (NN ERK) (NN inhibitor)) (-RRB- -RRB-))) (, ,)) (VP (VB Go) (S (NP (NP (NP (NP (NN 6976)) (PRN (-LRB- -LRB-) (NP (DT a) (NN PKC) (NN inhibitor)) (-RRB- -RRB-))) (CC and) (NP (NNP Bay) (CD 11-7082))) (PRN (-LRB- -LRB-) (NP (DT a) (NN NF-kappaB) (NN inhibitor)) (-RRB- -RRB-))) (ADVP (RB significantly)) (VP (VBN decreased) (NP (JJ LTA-stimulated) (JJ oxidative) (NN burst)) (PP (IN in) (NP (NP (NNS heterophils)) (PP (IN by) (NP (NP (CD 77) (NN %)) (, ,) (NP (CD 30) (NN %)) (, ,) (NP (CD 36) (NN %)) (, ,) (NP (CD 78) (NN %)) (, ,) (CC and) (NP (CD 61) (NN %)) (, ,) (ADVP (RB respectively))))))))) (. .)))
(S1 (S (S (NP (VBN Activated) (NN TLR2)) (VP (VBZ utilizes) (NP (NP (NN PI3-K)) (, ,) (NP (NN PLC)) (, ,) (NP (NN PKC)) (, ,) (NP (NN ERK)) (, ,) (CC and) (NP (NN NF-kappaB))) (PP (IN as) (NP (NP (NN signaling) (NNS factors)) (SBAR (WHNP (WDT that)) (S (VP (VBP mediate) (NP (NP (DT the) (JJ oxidative) (NN burst)) (PP (IN of) (NP (NN chicken) (NNS heterophils))))))))))) (. .)))
